What Biolife Solutions Inc does.

The following discussion of our business contains forward-looking statements that involve risks and uncertainties (see the section entitled “ Forward-Looking Statements ” herein). Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those factors set forth under “ Risk Factors ” and elsewhere in this Form 10-K.

We are a life sciences company that develops, manufactures, and markets bioproduction products and services which are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. Our products are used in basic and applied research and commercial manufacturing of biologic-based therapies. Customers use our products to maintain the health and function of biologic material during sourcing, manufacturing, and distribution.

We currently operate as one bioproduction products and services business which supports several steps in the biologic material manufacturing and delivery process. Our portfolio of tools and services focuses on biopreservation media and cell processing products. We have in-house expertise in cryobiology and the broader CGT workflow, and continue to evaluate opportunities to maximize the value of our product platforms for our extensive customer base through organic growth innovations, partnerships, and acquisitions.

Revenue and profit, by fiscal year.

More on BLFS.

• Biolife Solutions Inc summary
• Biolife Solutions Inc financial statements
• Biolife Solutions Inc key metrics
• Biolife Solutions Inc health scores and style box
• Biolife Solutions Inc earnings
• Biolife Solutions Inc dividends
• Biolife Solutions Inc valuation
• Biolife Solutions Inc ownership and insiders
• Biolife Solutions Inc peers

Figures from Biolife Solutions Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.